BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23281299)

  • 1. Assessing the drinking status of liver transplant patients with alcoholic liver disease.
    Allen JP; Wurst FM; Thon N; Litten RZ
    Liver Transpl; 2013 Apr; 19(4):369-76. PubMed ID: 23281299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption.
    Staufer K; Andresen H; Vettorazzi E; Tobias N; Nashan B; Sterneck M
    Hepatology; 2011 Nov; 54(5):1640-9. PubMed ID: 21809364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for detection of alcohol consumption in liver transplantation.
    Staufer K; Yegles M
    World J Gastroenterol; 2016 Apr; 22(14):3725-34. PubMed ID: 27076757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation.
    Erim Y; Böttcher M; Dahmen U; Beck O; Broelsch CE; Helander A
    Liver Transpl; 2007 May; 13(5):757-61. PubMed ID: 17457868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues.
    Ursic-Bedoya J; Faure S; Donnadieu-Rigole H; Pageaux GP
    World J Gastroenterol; 2015 Oct; 21(39):10994-1002. PubMed ID: 26494956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidates for liver transplantation with alcoholic liver disease: Psychosocial aspects.
    Telles-Correia D; Mega I
    World J Gastroenterol; 2015 Oct; 21(39):11027-33. PubMed ID: 26494959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl glucuronide and ethyl sulfate.
    Walsham NE; Sherwood RA
    Adv Clin Chem; 2014; 67():47-71. PubMed ID: 25735859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.
    Tandon P; Goodman KJ; Ma MM; Wong WW; Mason AL; Meeberg G; Bergsten D; Carbonneau M; Bain VG
    Am J Gastroenterol; 2009 Jul; 104(7):1700-6. PubMed ID: 19471253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Direct metabolites of ethanol as biological markers of alcohol use: basic aspects and applications].
    Thon N; Weinmann W; Yegles M; Preuss U; Wurst FM
    Fortschr Neurol Psychiatr; 2013 Sep; 81(9):493-502. PubMed ID: 23856980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery.
    Weinrieb RM; Van Horn DH; McLellan AT; Lucey MR
    Liver Transpl; 2000 Nov; 6(6):769-76. PubMed ID: 11084066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting.
    Helander A; Péter O; Zheng Y
    Alcohol Alcohol; 2012; 47(5):552-7. PubMed ID: 22691387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates.
    Sterneck M; Yegles M; Rothkirch von G; Staufer K; Vettorazzi E; Schulz KH; Tobias N; Graeser C; Fischer L; Nashan B; Andresen-Streichert H
    Liver Int; 2014 Mar; 34(3):469-76. PubMed ID: 23829409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study.
    Andresen-Streichert H; Beres Y; Weinmann W; Schröck A; Müller A; Skopp G; Pischke S; Vettorazzi E; Lohse A; Nashan B; Sterneck M
    Transpl Int; 2017 Jun; 30(6):611-620. PubMed ID: 28295675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease.
    DiMartini A; Day N; Lane T; Beisler AT; Dew MA; Anton R
    Alcohol Clin Exp Res; 2001 Dec; 25(12):1729-33. PubMed ID: 11781505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in transplantation for alcoholic liver disease.
    Berlakovich GA
    World J Gastroenterol; 2014 Jul; 20(25):8033-9. PubMed ID: 25009374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic transplant in alcoholic hepatopathy].
    Bustamante Schneider J; Fernández Ramos JR
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():64-9. PubMed ID: 11279896
    [No Abstract]   [Full Text] [Related]  

  • 18. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
    Halm U; Tannapfel A; Mössner J; Berr F
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of alcohol consumption in liver transplant candidates and recipients: the best combination of the tools available.
    Piano S; Marchioro L; Gola E; Rosi S; Morando F; Cavallin M; Sticca A; Fasolato S; Forza G; Chiara Frigo A; Plebani M; Zanus G; Cillo U; Gatta A; Angeli P
    Liver Transpl; 2014 Jul; 20(7):815-22. PubMed ID: 24692331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biomarkers can detect early-stage alcohol problems].
    Helander A
    Lakartidningen; 2011 Oct 9-15; 108(45):2291-5. PubMed ID: 22242244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.